Malignant Pleural Effusion: Palliative Managements and Indication for Pleurodesis Based on Survival Scores.

IF 2 3区医学 Q3 ONCOLOGY

Journal of Surgical Oncology Pub Date : 2025-05-20 DOI:10.1002/jso.28156

Erlon de Avila Carvalho, Rachid Eduardo Noleto da Nobrega Oliveira, José Henrique Agner Ribeiro, Jefferson Luís Gross, Cezar Augusto Vendas Galhardo, Heládio Feitosa E Castro Neto, Giovana Dos Santos, Reitan Ribeiro, Alexandre Ferreira Oliveira, Rodrigo Nascimento Pinheiro

引用次数: 0

Abstract

Neoplastic pleural effusion is one in which malignant neoplastic cells are detected in the pleural fluid or in the parietal pleura. When secondary, it confirms disseminated neoplastic disease and suggests a reduced life expectancy and low quality of life. This review was described by a group of physician members of the Brazilian Society of Oncological Surgery regarding the treatment of neoplastic pleural effusion, developed to guide surgeons, palliative care physicians and clinical oncologists in their clinical practice to assess patients indicated for pleurodesis based on survival scores.

查看原文本刊更多论文

恶性胸膜积液：基于生存评分的胸膜积液的姑息治疗和指征。

肿瘤性胸腔积液是在胸腔液或胸膜壁层中发现恶性肿瘤细胞的一种。当继发时，它证实播散性肿瘤疾病，并提示预期寿命缩短和生活质量低下。这篇综述是由巴西肿瘤外科学会的一组医生成员描述的，关于肿瘤性胸腔积液的治疗，旨在指导外科医生、姑息治疗医生和临床肿瘤学家在临床实践中根据生存评分评估胸膜穿刺患者的适应症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Surgical Oncology 医学-外科

CiteScore

4.70

自引率

4.00%

发文量

367

审稿时长

2 months

期刊介绍： The Journal of Surgical Oncology offers peer-reviewed, original papers in the field of surgical oncology and broadly related surgical sciences, including reports on experimental and laboratory studies. As an international journal, the editors encourage participation from leading surgeons around the world. The JSO is the representative journal for the World Federation of Surgical Oncology Societies. Publishing 16 issues in 2 volumes each year, the journal accepts Research Articles, in-depth Reviews of timely interest, Letters to the Editor, and invited Editorials. Guest Editors from the JSO Editorial Board oversee multiple special Seminars issues each year. These Seminars include multifaceted Reviews on a particular topic or current issue in surgical oncology, which are invited from experts in the field.